Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

$24.99

Analysis of Goodwill and Intangible Assets

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Goodwill and Intangible Asset Disclosure

Bristol-Myers Squibb Co., balance sheet: goodwill and intangible assets

US$ in millions

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Goodwill
R&D technology
Acquired marketed product rights
Capitalized software
IPRD
Other intangible assets, gross carrying amounts
Accumulated amortization
Other intangible assets, net
Goodwill and other intangible assets

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


An examination of the reported values reveals several noteworthy trends in goodwill and intangible assets over the five-year period. Overall, a general decline in the aggregate value of these assets is apparent. While goodwill itself demonstrates relative stability with modest increases, significant changes are observed within the components of other intangible assets, particularly in net values.

Goodwill
Goodwill experienced a gradual increase from US$20,502 million in 2021 to US$21,754 million in 2025. The increases between 2021 and 2022, and 2023 and 2024 were relatively consistent. This suggests a consistent approach to acquisitions or a lack of significant impairment charges during the period.
R&D Technology
R&D technology was not reported for 2021 and 2022. It first appears in 2024 at US$1,980 million and remains constant through 2025. This suggests a recent capitalization of research and development expenses, potentially related to a specific project or initiative.
Acquired Marketed Product Rights
Acquired marketed product rights represent a substantial portion of intangible assets. These rights increased from US$60,761 million in 2021 to US$63,076 million in 2023, then decreased to US$61,385 million in 2025. The initial increase may reflect new acquisitions, while the subsequent decline could be due to amortization or impairment.
Capitalized Software
Capitalized software values remained relatively stable, fluctuating between US$1,497 million and US$1,555 million. A slight decrease is observed in 2025 to US$1,453 million, potentially due to amortization or write-downs.
IPRD
IPRD demonstrates significant volatility. It increased substantially from US$3,750 million in 2021 to US$6,560 million in 2022, then decreased to US$3,710 million in 2023, and increased again to US$7,985 million in 2024 before decreasing to US$7,600 million in 2025. This suggests active management of intellectual property rights, potentially through acquisitions, disposals, or changes in valuation.
Other Intangible Assets
Gross carrying amounts for other intangible assets increased from US$66,010 million in 2021 to US$73,340 million in 2024, then decreased to US$72,418 million in 2025. However, accumulated amortization increased consistently throughout the period, from -US$23,483 million in 2021 to -US$53,315 million in 2025. Consequently, the net value of other intangible assets decreased substantially, from US$42,527 million in 2021 to US$19,103 million in 2025. This indicates significant amortization expense impacting the reported value.
Aggregate Value
The combined value of goodwill and other intangible assets decreased from US$63,029 million in 2021 to US$40,857 million in 2025. This decline is primarily driven by the reduction in net other intangible assets, despite the relative stability of goodwill.

The consistent increase in accumulated amortization suggests a systematic reduction in the carrying value of intangible assets. The fluctuations in IPRD and the decline in net other intangible assets warrant further investigation to understand the underlying drivers and potential implications for future financial performance.


Adjustments to Financial Statements: Removal of Goodwill

Bristol-Myers Squibb Co., adjustments to financial statements

US$ in millions

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Adjustment to Total Assets
Total assets (as reported)
Less: Goodwill
Total assets (adjusted)
Adjustment to Total BMS Shareholders’ Equity
Total BMS shareholders’ equity (as reported)
Less: Goodwill
Total BMS shareholders’ equity (adjusted)

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


A significant reduction in total assets is observed over the five-year period. Reported total assets decreased from US$109,314 million in 2021 to US$90,038 million in 2025, representing a cumulative decline of approximately 17.7%. The adjusted total assets exhibit a more pronounced decrease, falling from US$88,812 million in 2021 to US$68,284 million in 2025, a cumulative reduction of roughly 23.1%. This disparity suggests a substantial impact from the adjustments made, specifically related to the removal of goodwill and intangible assets.

Shareholders’ equity also demonstrates a declining trend, although with some fluctuation. Reported total shareholders’ equity decreased from US$35,946 million in 2021 to US$18,473 million in 2025, a decrease of approximately 48.6%. However, the adjusted shareholders’ equity shows a more dramatic decline, moving from US$15,444 million in 2021 to a negative value of US$-3,281 million in 2025. This indicates that the adjustments have a considerable negative impact on the net worth attributable to shareholders.

Asset Adjustments
The difference between reported and adjusted total assets widens over time. In 2021, the adjustment reduced total assets by approximately US$20.5 billion. By 2025, the adjustment resulted in a reduction of approximately US$21.75 billion. This suggests a consistent and growing impact from the removal of goodwill and related intangible assets from the balance sheet.
Equity Impact
The adjusted shareholders’ equity becomes negative in 2024 and remains so in 2025. This is a critical observation, as negative equity implies that the company’s liabilities exceed its assets, raising concerns about solvency. The magnitude of the adjustment to equity is substantially larger than the adjustment to assets, indicating that a significant portion of the reported equity is tied to items being removed through the adjustments.

The rate of decline in adjusted assets and equity accelerates in the later years of the period. Between 2023 and 2024, adjusted total assets decreased by US$2,169 million, while adjusted shareholders’ equity decreased by US$1,169 million. Between 2024 and 2025, adjusted total assets decreased by US$2,719 million, and adjusted shareholders’ equity decreased by US$2,103 million. This acceleration suggests that the impact of the adjustments is becoming more pronounced over time.

The substantial adjustments to both total assets and shareholders’ equity, particularly the move to negative adjusted equity, warrant further investigation into the nature and rationale behind the removal of goodwill and intangible assets. The trends observed suggest a significant restructuring or reassessment of asset values.


Bristol-Myers Squibb Co., Financial Data: Reported vs. Adjusted


Adjusted Financial Ratios: Removal of Goodwill (Summary)

Bristol-Myers Squibb Co., adjusted financial ratios

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Total Asset Turnover
Reported total asset turnover
Adjusted total asset turnover
Financial Leverage
Reported financial leverage
Adjusted financial leverage
Return on Equity (ROE)
Reported ROE
Adjusted ROE
Return on Assets (ROA)
Reported ROA
Adjusted ROA

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The financial metrics demonstrate a significant impact from adjusting for goodwill and intangible assets. Removing these items from the calculations results in substantially altered ratios, particularly concerning profitability and leverage. Observed trends suggest a potentially more favorable underlying financial performance when goodwill is excluded, though some adjusted metrics exhibit volatility.

Total Asset Turnover
Reported total asset turnover exhibited an increasing trend from 0.42 in 2021 to 0.54 in 2025. However, the adjusted total asset turnover shows a more pronounced increase, moving from 0.52 in 2021 to 0.71 in 2025. This indicates that excluding goodwill and intangible assets suggests a more efficient use of assets in generating revenue.
Financial Leverage
Reported financial leverage increased from 3.04 in 2021 to 5.67 in 2024, before decreasing to 4.87 in 2025. In contrast, the adjusted financial leverage shows a substantial increase from 5.75 in 2021 to 8.96 in 2023, with values for 2024 and 2025 unavailable. This suggests that the reported leverage figures underestimate the true extent of financial risk when goodwill is considered, and the company’s reliance on debt is considerably higher when goodwill is excluded.
Return on Equity (ROE)
Reported ROE fluctuated considerably, increasing from 19.46% in 2021 to 27.27% in 2023, then declining sharply to -54.78% in 2024 before recovering to 38.19% in 2025. The adjusted ROE, however, demonstrates a consistently high and increasing trend, rising from 45.29% in 2021 to 97.14% in 2023, with values for 2024 and 2025 unavailable. This substantial difference highlights the significant impact of goodwill on reported equity and profitability. The volatility in reported ROE is largely mitigated when goodwill is removed from the calculation.
Return on Assets (ROA)
Reported ROA followed a similar pattern to ROE, increasing from 6.40% in 2021 to 8.43% in 2023, then declining to -9.66% in 2024 before recovering to 7.83% in 2025. The adjusted ROA also increased from 7.88% in 2021 to 10.85% in 2023, but then decreased to -12.62% in 2024 before recovering to 10.33% in 2025. While both metrics show similar fluctuations, the adjusted ROA consistently remains higher than the reported ROA, indicating that the company’s asset utilization is more profitable when goodwill is excluded. The negative values in 2024 for both reported and adjusted ROA suggest a period of significant losses relative to assets.

In summary, the adjustments for goodwill and intangible assets reveal a markedly different financial picture. The adjusted ratios suggest a more efficient operation and a higher degree of financial leverage than indicated by the reported figures. The substantial differences between reported and adjusted profitability metrics underscore the importance of considering the impact of these non-operating assets when evaluating the company’s financial performance.


Bristol-Myers Squibb Co., Financial Ratios: Reported vs. Adjusted


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Revenues
Total assets
Activity Ratio
Total asset turnover1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Revenues
Adjusted total assets
Activity Ratio
Adjusted total asset turnover2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Total asset turnover = Revenues ÷ Total assets
= ÷ =

2 Adjusted total asset turnover = Revenues ÷ Adjusted total assets
= ÷ =


An examination of the financial information reveals distinct trends in both total asset values and associated turnover ratios over the five-year period. Reported total assets demonstrate a consistent decline annually, while adjusted total assets also decrease, though at a slightly slower rate. The reported total asset turnover ratio exhibits an increasing trend, contrasting with the adjusted total asset turnover ratio, which shows a more pronounced and consistent upward movement.

Reported Total Assets
Reported total assets decreased from US$109,314 million in 2021 to US$90,038 million in 2025. This represents a cumulative reduction of approximately 17.6% over the period. The largest year-over-year decrease occurred between 2021 and 2022, with a reduction of US$12,494 million.
Adjusted Total Assets
Adjusted total assets also experienced a decline, moving from US$88,812 million in 2021 to US$68,284 million in 2025, a decrease of roughly 23.1%. The rate of decline appears relatively consistent year-over-year, suggesting a systematic reduction in assets when accounting for adjustments.
Reported Total Asset Turnover
The reported total asset turnover ratio increased from 0.42 in 2021 to 0.54 in 2025. This indicates improving efficiency in generating revenue relative to reported total assets. The increase was gradual between 2021 and 2023, then accelerated in the final two years of the observed period.
Adjusted Total Asset Turnover
The adjusted total asset turnover ratio demonstrates a stronger upward trend, rising from 0.52 in 2021 to 0.71 in 2025. This suggests a significant improvement in revenue generation when considering the adjusted asset base. The ratio increased from 0.61 in 2022 and 2023 to 0.68 in 2024 and 0.71 in 2025, indicating accelerating efficiency gains.

The divergence between the reported and adjusted total asset turnover ratios suggests that the adjustments made to total assets have a substantial impact on the assessment of asset efficiency. The consistently higher adjusted turnover ratio implies that the reported asset base may include items that do not contribute proportionally to revenue generation. The increasing trend in both ratios, particularly the adjusted ratio, indicates improving operational efficiency over the five-year period.


Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Total assets
Total BMS shareholders’ equity
Solvency Ratio
Financial leverage1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Adjusted total assets
Adjusted total BMS shareholders’ equity
Solvency Ratio
Adjusted financial leverage2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Financial leverage = Total assets ÷ Total BMS shareholders’ equity
= ÷ =

2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total BMS shareholders’ equity
= ÷ =


An examination of the financial information reveals a notable shift in reported and adjusted asset and equity positions between 2021 and 2025. Reported total assets decreased consistently over the period, while adjusted total assets exhibited a similar, though slightly more pronounced, decline. Concurrent with this asset reduction, reported total shareholders’ equity also decreased, with a significant drop observed in 2024, followed by a partial recovery in 2025. Adjusted shareholders’ equity experienced a more substantial and continuous decrease, moving into negative territory by 2024 and worsening in 2025.

Reported Financial Leverage
Reported financial leverage increased from 3.04 in 2021 to 3.23 in 2023, indicating a growing reliance on debt financing relative to equity. A substantial increase was then observed in 2024, reaching 5.67, before decreasing slightly to 4.87 in 2025. This suggests a period of increased financial risk followed by a modest stabilization.
Adjusted Financial Leverage
Adjusted financial leverage demonstrates a consistent upward trend from 5.75 in 2021 to 8.96 in 2023. The absence of values for 2024 and 2025 prevents assessment of whether this trend continued. The increasing ratio suggests a growing dependence on debt when considering adjustments to asset and equity valuations. The magnitude of the adjusted leverage is considerably higher than the reported leverage throughout the observed period.

The divergence between reported and adjusted figures, particularly in shareholders’ equity and financial leverage, warrants further investigation. The movement of adjusted shareholders’ equity into negative values raises concerns about the underlying asset base supporting the reported equity position. The increasing adjusted financial leverage, coupled with declining adjusted equity, indicates a potentially weakening financial structure when accounting for these adjustments.

Asset Trends
Both reported and adjusted total assets experienced declines throughout the period. The adjusted asset reduction is more significant, suggesting that the adjustments are primarily impacting asset valuations. This could be due to impairments, write-downs, or changes in accounting treatment of specific assets.
Equity Trends
The substantial decrease in adjusted shareholders’ equity, culminating in negative values, is a key observation. This suggests that the book value of equity may not accurately reflect the underlying economic value of the company’s net assets after adjustments. The reported equity decline, while less severe, still indicates a reduction in the ownership stake.

Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net earnings (loss) attributable to BMS
Total BMS shareholders’ equity
Profitability Ratio
ROE1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Net earnings (loss) attributable to BMS
Adjusted total BMS shareholders’ equity
Profitability Ratio
Adjusted ROE2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 ROE = 100 × Net earnings (loss) attributable to BMS ÷ Total BMS shareholders’ equity
= 100 × ÷ =

2 Adjusted ROE = 100 × Net earnings (loss) attributable to BMS ÷ Adjusted total BMS shareholders’ equity
= 100 × ÷ =


Shareholders’ equity, both as reported and adjusted, demonstrates significant fluctuations over the observed period. Reported shareholders’ equity decreased from US$35,946 million in 2021 to US$16,335 million in 2024 before a slight increase to US$18,473 million in 2025. The adjusted shareholders’ equity exhibits a more dramatic decline, moving from US$15,444 million in 2021 to a negative value of US$3,281 million by 2025.

Reported Return on Equity (ROE)
Reported ROE initially increased from 19.46% in 2021 to 27.27% in 2023, coinciding with the decrease in reported shareholders’ equity. A substantial decline to -54.78% occurred in 2024, followed by a significant recovery to 38.19% in 2025. This volatility suggests a sensitivity to changes in net income relative to the shrinking equity base.
Adjusted Return on Equity (ROE)
Adjusted ROE shows a strong upward trend from 45.29% in 2021 to a peak of 97.14% in 2023. Values for 2024 and 2025 are unavailable. The substantial increase in adjusted ROE, while adjusted shareholders’ equity is decreasing, indicates that the adjustments made to equity are having a significant impact on profitability metrics. The absence of values for the later years prevents a complete assessment of this trend.

The divergence between reported and adjusted ROE is noteworthy. The substantial decline in adjusted shareholders’ equity, culminating in a negative value, raises questions regarding the nature and impact of the adjustments being made. The large swings in reported ROE, particularly the negative value in 2024, warrant further investigation into the underlying drivers of net income and equity changes. The lack of adjusted ROE figures for 2024 and 2025 limits the ability to assess the sustainability of the observed trends.


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net earnings (loss) attributable to BMS
Total assets
Profitability Ratio
ROA1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Net earnings (loss) attributable to BMS
Adjusted total assets
Profitability Ratio
Adjusted ROA2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 ROA = 100 × Net earnings (loss) attributable to BMS ÷ Total assets
= 100 × ÷ =

2 Adjusted ROA = 100 × Net earnings (loss) attributable to BMS ÷ Adjusted total assets
= 100 × ÷ =


The period under review demonstrates fluctuating performance when examining both reported and adjusted return on assets. Total assets, both reported and adjusted, exhibit a consistent decline across the five-year span. However, the adjusted return on assets consistently exceeds the reported return on assets each year, suggesting the impact of goodwill and intangible assets significantly influences the reported figures.

Total Assets Trend
Reported total assets decreased from US$109,314 million in 2021 to US$90,038 million in 2025, representing a cumulative reduction of approximately 17.6%. Adjusted total assets followed a similar downward trajectory, declining from US$88,812 million to US$68,284 million, a decrease of roughly 23.1% over the same period. This consistent decline in asset base warrants further investigation into the drivers behind these reductions, such as divestitures, asset impairments, or amortization.
Reported Return on Assets (ROA)
Reported ROA initially increased from 6.40% in 2021 to 8.43% in 2023, before experiencing a substantial decline to -9.66% in 2024. A partial recovery was observed in 2025, with ROA reaching 7.83%. The negative ROA in 2024 is a significant outlier and requires detailed examination to understand the underlying causes, potentially related to substantial losses or write-downs.
Adjusted Return on Assets (ROA)
Adjusted ROA also showed an initial increase, rising from 7.88% in 2021 to a peak of 10.85% in 2023. Similar to the reported ROA, a sharp decrease occurred in 2024, resulting in an adjusted ROA of -12.62%. A recovery to 10.33% was then noted in 2025. The magnitude of the decline in the adjusted ROA is greater than that of the reported ROA, indicating that the adjustments made to total assets are having a more pronounced effect on profitability calculations during the 2024 downturn.

The correlation between the reported and adjusted ROA trends suggests that the presence of goodwill and intangible assets is a key factor influencing overall profitability as measured by ROA. The substantial declines in both ROA metrics in 2024, followed by a partial recovery in 2025, highlight a period of significant volatility. Further analysis is recommended to determine the specific events driving these fluctuations and to assess the long-term sustainability of the observed recovery.